375 related articles for article (PubMed ID: 4058549)
1. Long-term treatment of infantile nephropathic cystinosis with cysteamine.
da Silva VA; Zurbrügg RP; Lavanchy P; Blumberg A; Suter H; Wyss SR; Lüthy CM; Oetliker OH
N Engl J Med; 1985 Dec; 313(23):1460-3. PubMed ID: 4058549
[No Abstract] [Full Text] [Related]
2. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Nesterova G; Williams C; Bernardini I; Gahl WA
Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
[TBL] [Abstract][Full Text] [Related]
3. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].
Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F
Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971
[TBL] [Abstract][Full Text] [Related]
4. [Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation].
Oczachowska-Kulik AE; Lund AM; Skovby F; Pedersen EB
Ugeskr Laeger; 2011 Aug; 173(33):1958-62. PubMed ID: 21849135
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
6. Hematological manifestations of nephropathic cystinosis.
Emadi A; Burns KH; Confer B; Borowitz MJ; Streiff MB
Acta Haematol; 2008; 119(3):169-72. PubMed ID: 18493119
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
Smolin LA; Clark KF; Thoene JG; Gahl WA; Schneider JA
Pediatr Res; 1988 Jun; 23(6):616-20. PubMed ID: 3393396
[TBL] [Abstract][Full Text] [Related]
8. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
9. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
[TBL] [Abstract][Full Text] [Related]
10. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
[TBL] [Abstract][Full Text] [Related]
11. [Cystinosis in adults: A systemic disease].
Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
[TBL] [Abstract][Full Text] [Related]
12. Development of Fanconi syndrome during infancy in a patient with cystinosis.
Levtchenko E; Monnens L
Acta Paediatr; 2006 Mar; 95(3):379-80. PubMed ID: 16497654
[No Abstract] [Full Text] [Related]
13. Effects of cysteamine therapy in nephropathic cystinosis.
Yudkoff M; Foreman JW; Segal S
N Engl J Med; 1981 Jan; 304(3):141-5. PubMed ID: 7442733
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cystinosis using cysteamine].
Broyer M; Tete MJ
Ann Pediatr (Paris); 1990 Feb; 37(2):91-3. PubMed ID: 2321906
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine therapy for children with nephropathic cystinosis.
Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
[TBL] [Abstract][Full Text] [Related]
16. Treatment of infantile nephropathic cystinosis with cysteamine.
N Engl J Med; 1986 May; 314(20):1319-21. PubMed ID: 3702933
[No Abstract] [Full Text] [Related]
17. Quiz page. Fanconi syndrome caused by cystinosis, intermediate type.
Ram R; Swarnalatha G; Reddy PN; Prasad N; Dakshinamurty KV
Am J Kidney Dis; 2009 Dec; 54(6):xxxviii-xxxix. PubMed ID: 19932873
[No Abstract] [Full Text] [Related]
18. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA
Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134
[TBL] [Abstract][Full Text] [Related]
19. Intravenous cysteamine therapy for nephropathic cystinosis.
Gahl WA; Ingelfinger J; Mohan P; Bernardini I; Hyman PE; Tangerman A
Pediatr Res; 1995 Oct; 38(4):579-84. PubMed ID: 8559613
[TBL] [Abstract][Full Text] [Related]
20. Nephropathic cystinosis: ineffectiveness of cysteamine therapy for ocular changes.
Cantani A; Giardini O; Ciarnella Cantani A
Am J Ophthalmol; 1983 May; 95(5):713-4. PubMed ID: 6846466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]